Literature DB >> 879869

Failure of D-penicillamine to affect peripheral joint involvement in ankylosing spondylitis or HLA B27-associated arthropathy.

H A Bird, A S Dixon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 879869      PMCID： PMC1006684          DOI： 10.1136/ard.36.3.289

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  1 in total

1.  Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen.

Authors:  A J Dixon; J Davies; T L Dormandy; E B Hamilton; P J Holt; R M Mason; M Thompson; J C Weber; D W Zutshi
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103
  1 in total
  7 in total

Review 1.  Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis.

Authors:  J Zochling; D van der Heijde; M Dougados; J Braun
Journal:  Ann Rheum Dis       Date:  2005-08-26       Impact factor: 19.103

2.  D-penicillamine in the therapy of ankylosing spondylitis.

Authors:  K Tytman; K Bernacka; S Sierakowski
Journal:  Clin Rheumatol       Date:  1989-09       Impact factor: 2.980

Review 3.  Antirheumatic drugs: clinical pharmacology and therapeutic use.

Authors:  G L Craig; W W Buchanan
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

4.  Penicillamine in seronegative polyarthritis.

Authors:  I A Jaffe
Journal:  Ann Rheum Dis       Date:  1977-12       Impact factor: 19.103

Review 5.  Current guidelines for the drug treatment of ankylosing spondylitis.

Authors:  E Toussirot; D Wendling
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

6.  Ankylosing spondylitis. Current drug treatment.

Authors:  J T Gran; G Husby
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

7.  Serum and synovial fluid levels of angiotensin converting enzyme in polyarthritis.

Authors:  J R Lowe; J S Dixon; J A Guthrie; P McWhinney
Journal:  Ann Rheum Dis       Date:  1986-11       Impact factor: 19.103
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.